Navigation Links
2D-LC analysis of phosphopeptides in brain tissue using Ettan MDLC and Finnigan LTQ

Key words: phosphopeptide • two-dimensional liquid chromatography (2D-LC) • Ettan MDLC • LC-MS/MS • reversed-phase chromatography (RPC) • strong cation exchange (SCX) chromatography • linear ion trap mass spectrometer


A 2D–LC-MS method was developed to analyze phospho-peptides in mouse brain tissue. The trypsin-digested tissue was separated by strong cation exchange chromatography (SCX), followed by reversed-phase chromatography (RPC) using Ettan™ MDLC. The detection was performed by mass spectrometry using neutral loss of phosphoric acid to selectively detect the phosphorylated peptides. Several phosphorylation sites were found, and a strategy for confident assignment of these was developed.


Introduction
One of the most important post-translational modifications is phosphorylation of serine, threonine, or tyrosine residues. Phosphorylated proteins play important roles in a wide range of biological processes, such as signal transduction, apoptosis, and cell cycle control. Detection of phosphorylation sites by mass spectrometry in proteins extracted from biological material is hampered by the low abundance, low stoichiometry, and poor ionization of phosphopeptides (1).

In this work, a biocompatible nanoscale liquid chromatography (LC) system, Ettan MDLC, was used for separating phosphopeptides. No metal ions that can chelate phosphate groups are present in the fluid pathway of the LC system, resulting in highly sensitive analyses (2).

Separation of the tryptic peptides was performed in two dimensions, SCX followed by RPC. A Finnigan™ LTQ™ linear ion trap mass spectrometer was used for detecting phosphopeptides by fragmenting all peptides that exhibited a neutral loss of phosphoric acid.


Materials
Products used

Ettan MDLC 18-1176-44, 11-0008-41

NAP™ 10 Columns 17-0854-01

PlusOne™ DTT 17-1318-01

PlusOne Tris 17-1321-01

Trypsin, sequencing grade 17-6002-75


Other products required
Finnigan LTQ mass spectrometer (Thermo Electron)

TurboSEQUEST™ protein identification software (Thermo Electron)

BioBasic™ SCX, 2.1 x 250 mm (Thermo Electron)

Zorbax™ 300-SB C18 trap column, 300 µm i.d. x 5 mm, 3 µm (Agilent)

Zorbax 300-SB C18 analytical column, 75 µm i.d. x 150 mm, 3 µm (Agilent)

Ammonium bicarbonate (Merck)

Citric acid (Fluka)

Formic acid, ultrapure (Merck Suprapur™)

Iodoacetic acid (Merck)

Acetonitrile, HPLC grade

Water, HPLC grade


Methods
Sample preparation

Approximately 0.5 mg of mouse brain tissue was prepared according to the following procedure. The proteins were dissolved by adding 1 ml of 9 M urea with 50 mM DTT to the tissue and allowing it to incubate for 60 min at 20 °C. A 1-ml aliquot consisting of 8 M urea, 250 mM TrisHCl, and 125 mM iodoacetamide, pH 8.8, was added. The mixture was allowed to incubate for 60 min at 20 °C. A 1-ml aliquot of this mixture was buffer exchanged with 20 mM ammonium bicarbonate, pH 7.8, on a NAP-10 desalting column. The protein sample was digested with trypsin (concentration ratio of 50:1) for 2–24 h. The trypsin was then inactivated by adding formic acid to the sample.

Liquid chromatography
Using the offline 2D-LC configuration of the Ettan MDLC, 40 µg of trypsin-digested mouse brain sample was injected onto a 2.1 x 250-mm BioBasic SCX column and eluted at 100 µl/min with a linear salt gradient of 0–30% B over 40 min (A: 20 mM citric acid, pH 2.5, 25% CH3CN; B: A + 1 M NH4Cl). Fractions were collected twice every minute (Fig 1). The fractions were injected onto a 0.3 x 5-mm Zorbax RPC trap column, where they were desalted. RPC separation was performed on a Zorbax 0.075 x 150-mm analytical column at 250 nl/min with a linear gradient of 0–60% B over 50 min (A: 0.1% formic acid; B: 84% CH3CN and 0.1% formic acid), a step up to 100% B, and then holding at 100% B for 10 min. To increase throughput, one pair of columns was equilibrated while the other pair was used for analysis, a standard preprogrammed method on the Ettan MDLC.

Mass spectrometry
A Finnigan LTQ linear ion trap was used. The MS method consisted of a cycle combining one full MS scan with three MS/MS events (25% collision energy) followed by an MS3 event (35% collision energy) that was triggered upon detection of -98, -49, or -32.7 Da from the precursor (neutral loss of phosphoric acid, charge states 1+, 2+, and 3+). Dynamic exclusion duration was set to 30 s. The MS/MS and MS3 spectra from all the runs were searched using TurboSEQUEST protein identification software. Modifications were set to allow for the detection of oxidized Met (+16); carboxyamidomethylated Cys (+57); phosphorylated Ser, Thr, and Tyr (+80); and dehydrated Ser and Thr (-18).


Results and discussion
By injecting a large amount of sample and separating it on an analytical scale SCX column, collecting the fractions, and then injecting these onto a nanoscale LC, the peptides of low abundance, such as phosphopeptides, could be detected (3). Forty micrograms of a mouse brain tissue tryptic digest was first separated by SCX using salt gradient elution. The chromatogram is shown in Figure 2.

Thirty of the collected fractions were further analyzed by LC-MS using the neutral loss function. Phosphopeptides were found in one-third of the analyzed SCX fractions as shown in Figure 2. They mainly eluted early in the salt gradient due to their reduced charge state (4). SCX can therefore be used as a phosphopeptide enrichment strategy.

An ion chromatogram and the MS3 events (i.e. where a neutral loss was detected) from one of the fractions are shown in Figure 3.

The phosphopeptides were found and the phosphorylation sites identified by TurboSEQUEST database searches on all MS3 spectra. The results were confirmed manually by studying the raw spectra. It was important to confirm that the charge state of the peptide was correct, that the neutral loss ion dominated the MS/MS spectrum (Fig 4), and that the sequence data was of high quality.

Database searches were then performed on all MS/MS spectra, and the results were used to confirm the MS/MS searches and to find tyrosine phosphorylations. Phospho-tyrosine does not lose phosphoric acid during collision in the ion trap; therefore, sequence data from MS/MS was used to find these phosphorylations (+80). Some possible tyrosine phosphorylations were identified but need further evaluation. Tyrosine-phosphorylated proteins exist in very low abundance in cells and probably fall below the detection limit of the method.

In total, 60 phosphorylated peptides were found originating from 50 proteins. Some of the identified phosphorylation sites are shown in Table 1. The proteins presented in the table are all known phosphoproteins involved in cell growth and cell differentiation.

MS/MS and MS3 spectra of one previously known phospho-peptide originating from Stathmin 1 are shown in Figure 4. A previously unreported phosphorylation site originating from scaffold attachment factor B2 is shown in Figure 5. Scaffold attachment factor B2 has been reported to suppress estrogen receptors and might have an important role in breast cancer (4).


Conclusions
The strategy for analyzing phosphopeptides confidently is summarized here:
1. 2D-LC (SCX/RPC)

2. MS3 on all peptides that show neutral loss of phosphoric acid

3. TurboSEQUEST searches on all MS3 spectra (-18@ST)

4. Manual confirmation of charge state and that neutral loss dominates MS/MS spectra

5. Further confirmation by MS/MS searches (+80@STY)

To confidently assign phosphopeptides in a complex mixture such as a tryptic digest of brain tissue, two-dimensional separations are needed. 2D-LC separated the peptides with high resolution, and the neutral loss MS detection was very selective for phosphopeptides. Care had to be taken when interpreting the data to avoid false positives from the database searches.

To increase the number of identified phosphopeptides, a greater amount of starting material would be needed (5), and possibly another chromatographic enrichment step specific for phosphopeptides, for example using titanium oxide media (6).


References
1. Ficarro, S. B. et al. Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae. Nat. Biotechnol. 20, 301–305 (2002).

2. Application note: Highly sensitive phosphopeptide analysis using Ettan MDLC and a linear ion trap mass spectrometer, GE Healthcare, 11-0027-38, Edition AA (2005).

3. Beausoleil, S. A. et al. Large-scale characterization of HeLa cell nuclear phosphoproteins. Proc. Natl. Acad. Sci. USA 101, 12130–12135 (2004).

4. Jiang, S. et al. Scaffold attachment factor SAFB1 suppresses ERα-mediated transcription in part via interaction with N-CoR. Mol. Endocrinology 10.1210/me.2005-0100 (29 September 2005).

5. Ballif, B. A. et al. Phosphoproteomic analysis of the developing mouse brain. Mol. Cell. Proteomics 3, 1093–1101 (2004).

6. Pinkse, M. W. et al. Selective isolation at the femtomole level of phosphopeptides from proteolytic digests using 2D-NanoLC-ESI-MS/MS and titanium oxide precolumns. Anal. Chem. 76, 3935–3943 (2004).



back to top
'"/>

Source:


Page: All 1 2 3 4 5 6

Related biology technology :

1. High-throughput gene expression analysis to screen for anti-asthma drugs
2. Fully automated DNA purification and efficient multiplex PCR for analysis of microsatellite loci
3. Flow cytometric analysis of human primary cells using the Agilent 2100 bioanalyzer and on-chip staining
4. 2100 expert software Powerful software for the analysis of RNA, DNA, proteins, and cells with the Agilent 2100 bioanalyzer
5. Using the Agilent 2100 bioanalyzer for quality control of protein samples prior to MS-analysis
6. Microfluidic analysis of multiplex PCR products for the genotyping of Helicobacter pylori
7. High resolution DNA analysis with the DNA 500 and DNA 1000 LabChip kits
8. Extended data analysis using DeCyder EDA
9. Neurite outgrowth cell-by-cell analysis using the IN Cell Developer Toolbox
10. Laser Capture Microdissection of muscle fiber populations and expression analysis by RT-PCR
11. TSKgel ODS-100Z and TSKgel ODS-100V column series provides a universal solution for the analysis of samples containing acidic, basic, polar & non-polar compounds
Post Your Comments:
(Date:9/1/2015)... ... September 01, 2015 , ... Industry leader ... Asia Pacific. In this newly-created position, Gibbs will lead iLab’s business operations in ... suite of tools. This entails not only introducing iLab to potential partners but ...
(Date:8/31/2015)... Milpitas, Calif. (PRWEB) , ... August 31, 2015 ... ... earlier this year to bring together supply chain risk management and resiliency practitioners ... collaborate, develop and share best practices, and be recognized for their innovations and ...
(Date:8/31/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/k6lcp2/mexico_biomedical ) has announced ... - Growth, Trends & Forecasts (2014-2020)" report to ... Sensors market is estimated at $0.20 billion by 2018 ... The near future will bring biomedical sensors ... individual. These sensors can be set to trigger alerts ...
(Date:8/31/2015)... , Aug. 31, 2015  RXi Pharmaceuticals Corporation ... on discovering and developing innovative therapies primarily in ... that the 30-day review period following the filing ... ocular indications with the U.S. Food and Drug ... now active. Logo -  ...
Breaking Biology Technology:iLab Solutions Hires Gerard Gibbs, Director of Business Development, Asia Pacific 2iLab Solutions Hires Gerard Gibbs, Director of Business Development, Asia Pacific 3Global Supply Chain Resiliency Council Announces Incorporation and Web Site Launch 2Global Supply Chain Resiliency Council Announces Incorporation and Web Site Launch 3Mexico Biomedical Sensors Market Report 2015-2020 2RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 2RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 3RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 4
... Scientific Corporation (NYSE: BSX ) today announced ... outlook to stable from negative. In addition, Moody,s ... from Ba2 and its liquidity rating to SGL-2 from ... Moody,s said the revised rating outlook reflects: ...
... GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an Atlanta-based ... today announced its financial results for the fourth quarter ... summary of recent operational highlights for calendar year 2009 ... the fourth quarter ended December 31, 2008, as compared ...
... used to Discover New Blood Tests for Heart DiseaseWALTHAM, ... focused on the discovery and development of novel diagnostic ... and Development Agreement (CRADA) with the National Heart, Lung, ... Health and Boston University (BU).Under the agreement, ...
Cached Biology Technology:Moody's Raises Boston Scientific's Rating Outlook to Stable 2Moody's Raises Boston Scientific's Rating Outlook to Stable 3GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2008 Financial Results 2GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2008 Financial Results 3GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2008 Financial Results 4GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2008 Financial Results 5GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2008 Financial Results 6GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2008 Financial Results 7GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2008 Financial Results 8GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2008 Financial Results 9GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2008 Financial Results 10GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2008 Financial Results 11BG Medicine Signs Collaborative Research Agreement with the National Heart, Lung and Blood Institute (NHLBI), and Boston University 2BG Medicine Signs Collaborative Research Agreement with the National Heart, Lung and Blood Institute (NHLBI), and Boston University 3BG Medicine Signs Collaborative Research Agreement with the National Heart, Lung and Blood Institute (NHLBI), and Boston University 4
(Date:8/20/2015)... 2015   Sensory, Inc ., a Silicon ... experience and security of consumer electronics through state-of-the-art ... its TrulySecure™ is the first multimodal ... FIDO Certified™. The FIDO (Fast Identification ... FIDO UAF (Universal Authentication Framework) 1.0 specifications, which ...
(Date:8/18/2015)... 17, 2015 Research and Markets ( ... "Global Biometric Authentication & Identification Market: Focus ... Forecast, 2015-2020" report to their offering. ... systems market is expected to grow at an ... and generate over $25 billion (approximately) by 2020 ...
(Date:8/12/2015)... 2015  New research unveiled at Black Hat ... to steal users, fingerprints. Information released today by ... scanners on mobile devices, making the security of ... on mobile devices, HYPR Corp. recently released a ... systems with strong cryptographic security. More information on ...
Breaking Biology News(10 mins):TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 2TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 3TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 4TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 5Global Biometric Authentication & Identification Market 2015: Focus On Modality, Motility & Application - Estimation & Forecasts to 2020 for the $25 Billion Industry 2HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 2HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 3
... Nov. 27 Singulex Inc. today announced,that it ... develop,immunoassays on the company,s Erenna(TM) system. Singulex has ... its Erenna Technology Access Program,(ETAP) and has begun ... precisely measure specific biomarkers in human blood., ...
... the University of Liverpool have been awarded 5 million to ... UV radiation. Biologists at Liverpool will investigate the ... decide when to die. NFkB governs responses within cells ... when this system goes wrong it is thought that it ...
... for storing electricity from renewable energy sources such as ... and Cleantech Ventures have invested in technology start-up Smart ... solutions., Director of the CSIRO Energy Transformed National Research ... technology aims to deliver a low cost, high performance, ...
Cached Biology News:Singulex Teams With Wyeth Pharmaceuticals to Translate Pre-Clinical Biomarker Research Into Clinical Study Design 2Smarter energy storage for solar and wind power 2
... Immulon ... surface to provide increased binding affinity ... Flat bottom works well for ... optical characteristics., Each ...
...
Ethylene glycol-bis(2-aminoethyl ether)-N,N,N',N'-tetraacetic acid, Molecular Biology Grade...
... Acridinium esters have moderate chemiluminescence efficiencies and ... understood. They have the added benefit that ... little to the background signal. This benefit ... high sensitivity immunoassay applications. These compounds can ...
Biology Products: